Twist Bioscience Corporation (TWST)

NASDAQ: TWST · IEX Real-Time Price · USD
-0.42 (-1.09%)
At close: Feb 23, 2024, 4:00 PM
+0.20 (0.52%)
After-hours: Feb 23, 2024, 5:45 PM EST

Twist Bioscience Revenue

Twist Bioscience had revenue of $262.36M in the twelve months ending December 31, 2023, with 21.58% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $71.50M with 31.81% year-over-year growth. In the fiscal year ending September 30, 2023, Twist Bioscience had annual revenue of $245.11M with 20.41% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
2.18B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Sep 30, 2023245.11M41.54M20.41%
Sep 30, 2022203.57M71.23M53.83%
Sep 30, 2021132.33M42.23M46.87%
Sep 30, 202090.10M35.72M65.67%
Sep 30, 201954.39M28.96M113.89%
Sep 30, 201825.43M14.66M136.16%
Sep 30, 201710.77M8.50M374.53%
Sep 30, 20162.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AMN Healthcare Services 3.79B
Privia Health Group 1.58B
NeoGenomics 591.64M
Corcept Therapeutics 482.38M
Alphatec Holdings 450.24M
Schrödinger 199.38M
Vericel 185.21M
Alpine Immune Sciences 30.80M
Revenue Rankings